(848511, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0000188', 'abnormal circulating glucose level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(848512, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848513, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031078', 'increased circulating troponin T level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848514, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848515, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848516, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848517, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848518, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848519, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848520, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011887', 'decreased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848521, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848522, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848523, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848524, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848525, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848526, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848527, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848528, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848529, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848530, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848531, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848532, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848533, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848534, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012618', 'decreased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848535, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848536, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848537, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848538, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848539, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848540, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848541, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848542, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848543, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848544, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848545, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848546, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011886', 'increased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848547, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848548, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0008548', 'abnormal circulating interferon level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848549, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848550, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848551, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848552, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848553, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848554, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848555, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848556, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848557, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020985', 'increased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848558, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848559, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848560, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848561, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848562, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0009699', 'hyperchylomicronemia', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848563, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848564, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0008588', 'abnormal circulating interleukin level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848565, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848566, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848567, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848568, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848569, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848570, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848571, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0003349', 'abnormal circulating renin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848572, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848573, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848574, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848575, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848576, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848577, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848578, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848579, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848580, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848581, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848582, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848583, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031243', 'abnormal circulating CSF3 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848584, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848585, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848586, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(848587, 'HP:0033450', 'Abnormal circulating prealbumin concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(848588, 'HP:0033533', 'Increased cardiac output', 'MP:0011927', 'abnormal cardiac valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848589, 'HP:0033533', 'Increased cardiac output', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848590, 'HP:0033533', 'Increased cardiac output', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848591, 'HP:0033533', 'Increased cardiac output', 'MP:0003928', 'increased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848592, 'HP:0033533', 'Increased cardiac output', 'MP:0003233', 'prolonged QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848593, 'HP:0033533', 'Increased cardiac output', 'MP:0004486', 'decreased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848594, 'HP:0033533', 'Increased cardiac output', 'MP:0004012', 'increased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848595, 'HP:0033533', 'Increased cardiac output', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848596, 'HP:0033533', 'Increased cardiac output', 'MP:0004156', 'abnormal QT variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848597, 'HP:0033533', 'Increased cardiac output', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848598, 'HP:0033533', 'Increased cardiac output', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848599, 'HP:0033533', 'Increased cardiac output', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848600, 'HP:0033533', 'Increased cardiac output', 'MP:0013127', 'epistaxis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848601, 'HP:0033533', 'Increased cardiac output', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848602, 'HP:0033533', 'Increased cardiac output', 'MP:0004879', 'decreased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848603, 'HP:0033533', 'Increased cardiac output', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848604, 'HP:0033533', 'Increased cardiac output', 'MP:0004010', 'increased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848605, 'HP:0033533', 'Increased cardiac output', 'MP:0003438', 'abnormal carotid body physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848606, 'HP:0033533', 'Increased cardiac output', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848607, 'HP:0033533', 'Increased cardiac output', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848608, 'HP:0033533', 'Increased cardiac output', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848609, 'HP:0033533', 'Increased cardiac output', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848610, 'HP:0033533', 'Increased cardiac output', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848611, 'HP:0033533', 'Increased cardiac output', 'MP:0010855', 'pulmonary hyperemia', 0.43243243243243246, 10.512629669126985, 2.1321355536367617, 'UPHENO:0051097', 'abnormal blood circulation'),
(848612, 'HP:0033533', 'Increased cardiac output', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848613, 'HP:0033533', 'Increased cardiac output', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848614, 'HP:0033533', 'Increased cardiac output', 'MP:0031170', 'abnormal vasculature physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848615, 'HP:0033533', 'Increased cardiac output', 'MP:0004070', 'abnormal P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848616, 'HP:0033533', 'Increased cardiac output', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848617, 'HP:0033533', 'Increased cardiac output', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848618, 'HP:0033533', 'Increased cardiac output', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848619, 'HP:0033533', 'Increased cardiac output', 'MP:0003549', 'pulmonary hypotension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848620, 'HP:0033533', 'Increased cardiac output', 'MP:0003898', 'abnormal QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848621, 'HP:0033533', 'Increased cardiac output', 'MP:0010512', 'absent PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848622, 'HP:0033533', 'Increased cardiac output', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848623, 'HP:0033533', 'Increased cardiac output', 'MP:0005532', 'abnormal vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848624, 'HP:0033533', 'Increased cardiac output', 'MP:0003547', 'abnormal pulmonary pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848625, 'HP:0033533', 'Increased cardiac output', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848626, 'HP:0033533', 'Increased cardiac output', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848627, 'HP:0033533', 'Increased cardiac output', 'MP:0004245', 'genital hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848628, 'HP:0033533', 'Increased cardiac output', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848629, 'HP:0033533', 'Increased cardiac output', 'MP:0031080', 'pulmonary embolism', 0.43243243243243246, 10.512629669126985, 2.1321355536367617, 'UPHENO:0051097', 'abnormal blood circulation'),
(848630, 'HP:0033533', 'Increased cardiac output', 'MP:0003394', 'increased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848631, 'HP:0033533', 'Increased cardiac output', 'MP:0011928', 'abnormal mitral valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848632, 'HP:0033533', 'Increased cardiac output', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848633, 'HP:0033533', 'Increased cardiac output', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848634, 'HP:0033533', 'Increased cardiac output', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848635, 'HP:0033533', 'Increased cardiac output', 'MP:0010509', 'decreased P wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848636, 'HP:0033533', 'Increased cardiac output', 'MP:0011514', 'skin hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848637, 'HP:0033533', 'Increased cardiac output', 'MP:0002128', 'abnormal blood circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848638, 'HP:0033533', 'Increased cardiac output', 'MP:0031152', 'subcutaneous hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848639, 'HP:0033533', 'Increased cardiac output', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848640, 'HP:0033533', 'Increased cardiac output', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848641, 'HP:0033533', 'Increased cardiac output', 'MP:0010519', 'atrioventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848642, 'HP:0033533', 'Increased cardiac output', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848643, 'HP:0033533', 'Increased cardiac output', 'MP:0003901', 'abnormal PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848644, 'HP:0033533', 'Increased cardiac output', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848645, 'HP:0033533', 'Increased cardiac output', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848646, 'HP:0033533', 'Increased cardiac output', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848647, 'HP:0033533', 'Increased cardiac output', 'MP:0003900', 'shortened QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848648, 'HP:0033533', 'Increased cardiac output', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848649, 'HP:0033533', 'Increased cardiac output', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848650, 'HP:0033533', 'Increased cardiac output', 'MP:0006111', 'abnormal coronary circulation', 0.5, 10.512629669126985, 2.2926654432261793, 'UPHENO:0051097', 'abnormal blood circulation'),
(848651, 'HP:0033533', 'Increased cardiac output', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848652, 'HP:0033533', 'Increased cardiac output', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848653, 'HP:0033533', 'Increased cardiac output', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848654, 'HP:0033533', 'Increased cardiac output', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848655, 'HP:0033533', 'Increased cardiac output', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848656, 'HP:0033533', 'Increased cardiac output', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848657, 'HP:0033533', 'Increased cardiac output', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848658, 'HP:0033533', 'Increased cardiac output', 'MP:0004878', 'increased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848659, 'HP:0033533', 'Increased cardiac output', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848660, 'HP:0033533', 'Increased cardiac output', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848661, 'HP:0033533', 'Increased cardiac output', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848662, 'HP:0033533', 'Increased cardiac output', 'MP:0001634', 'internal hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848663, 'HP:0033533', 'Increased cardiac output', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848664, 'HP:0033533', 'Increased cardiac output', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848665, 'HP:0033533', 'Increased cardiac output', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848666, 'HP:0033533', 'Increased cardiac output', 'MP:0003896', 'prolonged PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848667, 'HP:0033533', 'Increased cardiac output', 'MP:0003037', 'increased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848668, 'HP:0033533', 'Increased cardiac output', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848669, 'HP:0033533', 'Increased cardiac output', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848670, 'HP:0033533', 'Increased cardiac output', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848671, 'HP:0033533', 'Increased cardiac output', 'MP:0001598', 'abnormal blood viscosity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848672, 'HP:0033533', 'Increased cardiac output', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848673, 'HP:0033533', 'Increased cardiac output', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848674, 'HP:0033533', 'Increased cardiac output', 'MP:0010554', 'shortened HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848675, 'HP:0033533', 'Increased cardiac output', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848676, 'HP:0033533', 'Increased cardiac output', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848677, 'HP:0033533', 'Increased cardiac output', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848678, 'HP:0033533', 'Increased cardiac output', 'MP:0001599', 'abnormal blood volume', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848679, 'HP:0033533', 'Increased cardiac output', 'MP:0006048', 'pulmonary valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848680, 'HP:0033533', 'Increased cardiac output', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848681, 'HP:0033533', 'Increased cardiac output', 'MP:0010514', 'fragmented QRS complex', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848682, 'HP:0033533', 'Increased cardiac output', 'MP:0011926', 'abnormal heart valve physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848683, 'HP:0033533', 'Increased cardiac output', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848684, 'HP:0033533', 'Increased cardiac output', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848685, 'HP:0033533', 'Increased cardiac output', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848686, 'HP:0033533', 'Increased cardiac output', 'MP:0004071', 'prolonged P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848687, 'HP:0033533', 'Increased cardiac output', 'MP:0011952', 'decreased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848688, 'HP:0033533', 'Increased cardiac output', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848689, 'HP:0033533', 'Increased cardiac output', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848690, 'HP:0033533', 'Increased cardiac output', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848691, 'HP:0033533', 'Increased cardiac output', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848692, 'HP:0033533', 'Increased cardiac output', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848693, 'HP:0033533', 'Increased cardiac output', 'MP:0020096', 'high mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848694, 'HP:0033533', 'Increased cardiac output', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848695, 'HP:0033533', 'Increased cardiac output', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848696, 'HP:0033533', 'Increased cardiac output', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848697, 'HP:0033533', 'Increased cardiac output', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848698, 'HP:0033533', 'Increased cardiac output', 'MP:0010516', 'absent Q wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848699, 'HP:0033533', 'Increased cardiac output', 'MP:0001914', 'hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848700, 'HP:0033533', 'Increased cardiac output', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848701, 'HP:0033533', 'Increased cardiac output', 'MP:0000249', 'abnormal blood vessel physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848702, 'HP:0033533', 'Increased cardiac output', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848703, 'HP:0033533', 'Increased cardiac output', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848704, 'HP:0033533', 'Increased cardiac output', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848705, 'HP:0033533', 'Increased cardiac output', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848706, 'HP:0033533', 'Increased cardiac output', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848707, 'HP:0033533', 'Increased cardiac output', 'MP:0006049', 'semilunar valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848708, 'HP:0033533', 'Increased cardiac output', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848709, 'HP:0033533', 'Increased cardiac output', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848710, 'HP:0033533', 'Increased cardiac output', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848711, 'HP:0033533', 'Increased cardiac output', 'MP:0009384', 'cardiac valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848712, 'HP:0033533', 'Increased cardiac output', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848713, 'HP:0033533', 'Increased cardiac output', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848714, 'HP:0033533', 'Increased cardiac output', 'MP:0005435', 'hemoperitoneum', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848715, 'HP:0033533', 'Increased cardiac output', 'MP:0011951', 'increased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848716, 'HP:0033533', 'Increased cardiac output', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848717, 'HP:0033533', 'Increased cardiac output', 'MP:0011938', 'prolonged PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848718, 'HP:0033533', 'Increased cardiac output', 'MP:0013135', 'poor circulation in tail', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848719, 'HP:0033533', 'Increased cardiac output', 'MP:0001636', 'irregular heartbeat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848720, 'HP:0033533', 'Increased cardiac output', 'MP:0010393', 'shortened QRS complex duration', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848721, 'HP:0033533', 'Increased cardiac output', 'MP:0020345', 'abnormal myocardial fiber currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848722, 'HP:0033533', 'Increased cardiac output', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848723, 'HP:0033533', 'Increased cardiac output', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848724, 'HP:0033533', 'Increased cardiac output', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848725, 'HP:0033533', 'Increased cardiac output', 'MP:0001629', 'abnormal heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848726, 'HP:0033533', 'Increased cardiac output', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848727, 'HP:0033533', 'Increased cardiac output', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848728, 'HP:0033533', 'Increased cardiac output', 'MP:0010552', 'abnormal HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848729, 'HP:0033533', 'Increased cardiac output', 'MP:0009698', 'heart hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848730, 'HP:0033533', 'Increased cardiac output', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848731, 'HP:0033533', 'Increased cardiac output', 'MP:0031130', 'right-to-left shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848732, 'HP:0033533', 'Increased cardiac output', 'MP:0010504', 'abnormal RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848733, 'HP:0033533', 'Increased cardiac output', 'MP:0001596', 'hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848734, 'HP:0033533', 'Increased cardiac output', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848735, 'HP:0033533', 'Increased cardiac output', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848736, 'HP:0033533', 'Increased cardiac output', 'MP:0005243', 'hemothorax', 0.41025641025641024, 10.512629669126985, 2.0767459426735546, 'UPHENO:0051097', 'abnormal blood circulation'),
(848737, 'HP:0033533', 'Increased cardiac output', 'MP:0011953', 'prolonged PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848738, 'HP:0033533', 'Increased cardiac output', 'MP:0010515', 'abnormal Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848739, 'HP:0033533', 'Increased cardiac output', 'MP:0006045', 'mitral valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848740, 'HP:0033533', 'Increased cardiac output', 'MP:0011918', 'abnormal PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848741, 'HP:0033533', 'Increased cardiac output', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848742, 'HP:0033533', 'Increased cardiac output', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848743, 'HP:0033533', 'Increased cardiac output', 'MP:0010559', 'heart block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848744, 'HP:0033533', 'Increased cardiac output', 'MP:0010637', 'sinus bradycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848745, 'HP:0033533', 'Increased cardiac output', 'MP:0005599', 'increased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848746, 'HP:0033533', 'Increased cardiac output', 'MP:0003034', 'increased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848747, 'HP:0033533', 'Increased cardiac output', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848748, 'HP:0033533', 'Increased cardiac output', 'MP:0002295', 'abnormal pulmonary circulation', 0.4444444444444444, 10.512629669126985, 2.1615457091963903, 'UPHENO:0051097', 'abnormal blood circulation'),
(848749, 'HP:0033533', 'Increased cardiac output', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848750, 'HP:0033533', 'Increased cardiac output', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848751, 'HP:0033533', 'Increased cardiac output', 'MP:0006112', 'angina', 0.48484848484848486, 10.512629669126985, 2.257660861788025, 'UPHENO:0051097', 'abnormal blood circulation'),
(848752, 'HP:0033533', 'Increased cardiac output', 'MP:0010560', 'intraventricular block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848753, 'HP:0033533', 'Increased cardiac output', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848754, 'HP:0033533', 'Increased cardiac output', 'MP:0001633', 'poor circulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848755, 'HP:0033533', 'Increased cardiac output', 'MP:0006138', 'congestive heart failure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848756, 'HP:0033533', 'Increased cardiac output', 'MP:0003882', 'abnormal pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848757, 'HP:0033533', 'Increased cardiac output', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848758, 'HP:0033533', 'Increased cardiac output', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848759, 'HP:0033533', 'Increased cardiac output', 'MP:0004086', 'absent heartbeat', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848760, 'HP:0033533', 'Increased cardiac output', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848761, 'HP:0033533', 'Increased cardiac output', 'MP:0003038', 'decreased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848762, 'HP:0033533', 'Increased cardiac output', 'MP:0006114', 'cardiac murmur', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848763, 'HP:0033533', 'Increased cardiac output', 'MP:0006047', 'aortic valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848764, 'HP:0033533', 'Increased cardiac output', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848765, 'HP:0033533', 'Increased cardiac output', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848766, 'HP:0033533', 'Increased cardiac output', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848767, 'HP:0033533', 'Increased cardiac output', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848768, 'HP:0033533', 'Increased cardiac output', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848769, 'HP:0033533', 'Increased cardiac output', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848770, 'HP:0033533', 'Increased cardiac output', 'MP:0000233', 'abnormal blood flow velocity', 0.5333333333333333, 10.512629669126985, 2.36785468801073, 'UPHENO:0051097', 'abnormal blood circulation'),
(848771, 'HP:0033533', 'Increased cardiac output', 'MP:0010571', 'shortened ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848772, 'HP:0033533', 'Increased cardiac output', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848773, 'HP:0033533', 'Increased cardiac output', 'MP:0010513', 'abnormal ventricular activation time', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848774, 'HP:0033533', 'Increased cardiac output', 'MP:0031128', 'cardiovascular shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848775, 'HP:0033533', 'Increased cardiac output', 'MP:0013134', 'poor circulation in autopods', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848776, 'HP:0033533', 'Increased cardiac output', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848777, 'HP:0033533', 'Increased cardiac output', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848778, 'HP:0033533', 'Increased cardiac output', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848779, 'HP:0033533', 'Increased cardiac output', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848780, 'HP:0033533', 'Increased cardiac output', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848781, 'HP:0033533', 'Increased cardiac output', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848782, 'HP:0033533', 'Increased cardiac output', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848783, 'HP:0033533', 'Increased cardiac output', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848784, 'HP:0033533', 'Increased cardiac output', 'MP:0000231', 'hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848785, 'HP:0033533', 'Increased cardiac output', 'MP:0011936', 'abnormal PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848786, 'HP:0033533', 'Increased cardiac output', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848787, 'HP:0033533', 'Increased cardiac output', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848788, 'HP:0033533', 'Increased cardiac output', 'MP:0003899', 'abnormal QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848789, 'HP:0033533', 'Increased cardiac output', 'MP:0004072', 'abnormal frontal plane axis', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848790, 'HP:0033533', 'Increased cardiac output', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848791, 'HP:0033533', 'Increased cardiac output', 'MP:0002952', 'ventricular cardiomyopathy', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848792, 'HP:0033533', 'Increased cardiac output', 'MP:0001627', 'abnormal cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848793, 'HP:0033533', 'Increased cardiac output', 'MP:0010553', 'prolonged HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848794, 'HP:0033533', 'Increased cardiac output', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848795, 'HP:0033533', 'Increased cardiac output', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848796, 'HP:0033533', 'Increased cardiac output', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848797, 'HP:0033533', 'Increased cardiac output', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848798, 'HP:0033533', 'Increased cardiac output', 'MP:0008950', 'ventricular tachycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848799, 'HP:0033533', 'Increased cardiac output', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848800, 'HP:0033533', 'Increased cardiac output', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848801, 'HP:0033533', 'Increased cardiac output', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848802, 'HP:0033533', 'Increased cardiac output', 'MP:0004217', 'salt-sensitive hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848803, 'HP:0033533', 'Increased cardiac output', 'MP:0010636', 'bundle branch block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848804, 'HP:0033533', 'Increased cardiac output', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848805, 'HP:0033533', 'Increased cardiac output', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848806, 'HP:0033533', 'Increased cardiac output', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848807, 'HP:0033533', 'Increased cardiac output', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848808, 'HP:0033533', 'Increased cardiac output', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848809, 'HP:0033533', 'Increased cardiac output', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848810, 'HP:0033533', 'Increased cardiac output', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848811, 'HP:0033533', 'Increased cardiac output', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848812, 'HP:0033533', 'Increased cardiac output', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848813, 'HP:0033533', 'Increased cardiac output', 'MP:0011937', 'shortened PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848814, 'HP:0033533', 'Increased cardiac output', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848815, 'HP:0033533', 'Increased cardiac output', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848816, 'HP:0033533', 'Increased cardiac output', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848817, 'HP:0033533', 'Increased cardiac output', 'MP:0010505', 'abnormal T wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848818, 'HP:0033533', 'Increased cardiac output', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848819, 'HP:0033533', 'Increased cardiac output', 'MP:0004085', 'abnormal heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848820, 'HP:0033533', 'Increased cardiac output', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848821, 'HP:0033533', 'Increased cardiac output', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848822, 'HP:0033533', 'Increased cardiac output', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848823, 'HP:0033533', 'Increased cardiac output', 'MP:0031129', 'left-to-right shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848824, 'HP:0033533', 'Increased cardiac output', 'MP:0006044', 'tricuspid valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848825, 'HP:0033533', 'Increased cardiac output', 'MP:0010511', 'shortened PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848826, 'HP:0033533', 'Increased cardiac output', 'MP:0012045', 'increased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848827, 'HP:0033533', 'Increased cardiac output', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848828, 'HP:0033533', 'Increased cardiac output', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848829, 'HP:0033533', 'Increased cardiac output', 'MP:0011929', 'abnormal aortic valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848830, 'HP:0033533', 'Increased cardiac output', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848831, 'HP:0033533', 'Increased cardiac output', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848832, 'HP:0033533', 'Increased cardiac output', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848833, 'HP:0033533', 'Increased cardiac output', 'MP:0011920', 'abnormal S wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848834, 'HP:0033533', 'Increased cardiac output', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848835, 'HP:0033533', 'Increased cardiac output', 'MP:0010394', 'decreased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848836, 'HP:0033533', 'Increased cardiac output', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848837, 'HP:0033533', 'Increased cardiac output', 'MP:0003897', 'abnormal ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848838, 'HP:0033533', 'Increased cardiac output', 'MP:0010634', 'increased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848839, 'HP:0033533', 'Increased cardiac output', 'MP:0031136', 'muscle hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848840, 'HP:0033533', 'Increased cardiac output', 'MP:0020097', 'low mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848841, 'HP:0033533', 'Increased cardiac output', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848842, 'HP:0033533', 'Increased cardiac output', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848843, 'HP:0033533', 'Increased cardiac output', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848844, 'HP:0033533', 'Increased cardiac output', 'MP:0012046', 'decreased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848845, 'HP:0033533', 'Increased cardiac output', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848846, 'HP:0033533', 'Increased cardiac output', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848847, 'HP:0033533', 'Increased cardiac output', 'MP:0005333', 'decreased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848848, 'HP:0033533', 'Increased cardiac output', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848849, 'HP:0033533', 'Increased cardiac output', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848850, 'HP:0033533', 'Increased cardiac output', 'MP:0008776', 'increased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848851, 'HP:0033533', 'Increased cardiac output', 'MP:0008817', 'hematoma', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848852, 'HP:0033533', 'Increased cardiac output', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848853, 'HP:0033533', 'Increased cardiac output', 'MP:0004485', 'increased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848854, 'HP:0033533', 'Increased cardiac output', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848855, 'HP:0033533', 'Increased cardiac output', 'MP:0010570', 'prolonged ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848856, 'HP:0033533', 'Increased cardiac output', 'MP:0010507', 'shortened RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848857, 'HP:0033533', 'Increased cardiac output', 'MP:0010506', 'prolonged RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848858, 'HP:0033533', 'Increased cardiac output', 'MP:0003823', 'increased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848859, 'HP:0033533', 'Increased cardiac output', 'MP:0009275', 'bruising', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848860, 'HP:0033533', 'Increased cardiac output', 'MP:0003548', 'pulmonary hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848861, 'HP:0033533', 'Increased cardiac output', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848862, 'HP:0033533', 'Increased cardiac output', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848863, 'HP:0033533', 'Increased cardiac output', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848864, 'HP:0033533', 'Increased cardiac output', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848865, 'HP:0033533', 'Increased cardiac output', 'MP:0011954', 'shortened PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848866, 'HP:0033533', 'Increased cardiac output', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848867, 'HP:0033533', 'Increased cardiac output', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848868, 'HP:0033533', 'Increased cardiac output', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848869, 'HP:0033533', 'Increased cardiac output', 'MP:0002626', 'increased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848870, 'HP:0033533', 'Increased cardiac output', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848871, 'HP:0033533', 'Increased cardiac output', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848872, 'HP:0033533', 'Increased cardiac output', 'MP:0009732', 'ventricular premature beat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848873, 'HP:0033533', 'Increased cardiac output', 'MP:0006265', 'increased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848874, 'HP:0033533', 'Increased cardiac output', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848875, 'HP:0033533', 'Increased cardiac output', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848876, 'HP:0033533', 'Increased cardiac output', 'MP:0003393', 'decreased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848877, 'HP:0033533', 'Increased cardiac output', 'MP:0006266', 'decreased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848878, 'HP:0033533', 'Increased cardiac output', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848879, 'HP:0033533', 'Increased cardiac output', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848880, 'HP:0033533', 'Increased cardiac output', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848881, 'HP:0033533', 'Increased cardiac output', 'MP:0003929', 'decreased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848882, 'HP:0033533', 'Increased cardiac output', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848883, 'HP:0033533', 'Increased cardiac output', 'MP:0004011', 'decreased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848884, 'HP:0033533', 'Increased cardiac output', 'MP:0010631', 'increased Q wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848885, 'HP:0033533', 'Increased cardiac output', 'MP:0010392', 'prolonged QRS complex duration', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848886, 'HP:0033533', 'Increased cardiac output', 'MP:0001182', 'lung hemorrhage', 0.41025641025641024, 10.512629669126985, 2.0767459426735546, 'UPHENO:0051097', 'abnormal blood circulation'),
(848887, 'HP:0033533', 'Increased cardiac output', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848888, 'HP:0033533', 'Increased cardiac output', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848889, 'HP:0033533', 'Increased cardiac output', 'MP:0010695', 'abnormal blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848890, 'HP:0033533', 'Increased cardiac output', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848891, 'HP:0033533', 'Increased cardiac output', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848892, 'HP:0033533', 'Increased cardiac output', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848893, 'HP:0033533', 'Increased cardiac output', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848894, 'HP:0033533', 'Increased cardiac output', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848895, 'HP:0033533', 'Increased cardiac output', 'MP:0010520', 'sinoatrial block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848896, 'HP:0033533', 'Increased cardiac output', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848897, 'HP:0033533', 'Increased cardiac output', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848898, 'HP:0033533', 'Increased cardiac output', 'MP:0010510', 'absent P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848899, 'HP:0033533', 'Increased cardiac output', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848900, 'HP:0033533', 'Increased cardiac output', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848901, 'HP:0033533', 'Increased cardiac output', 'MP:0031192', 'coronary artery spasm', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848902, 'HP:0033533', 'Increased cardiac output', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848903, 'HP:0033533', 'Increased cardiac output', 'MP:0011919', 'abnormal R wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848904, 'HP:0033533', 'Increased cardiac output', 'MP:0031179', 'abnormal brain blood flow rate', 0.41025641025641024, 10.512629669126985, 2.0767459426735546, 'UPHENO:0051097', 'abnormal blood circulation'),
(848905, 'HP:0033533', 'Increased cardiac output', 'MP:0004216', 'salt-resistant hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848906, 'HP:0033533', 'Increased cardiac output', 'MP:0004120', 'cardiac ischemia', 0.48484848484848486, 10.512629669126985, 2.257660861788025, 'UPHENO:0051097', 'abnormal blood circulation'),
(848907, 'HP:0033533', 'Increased cardiac output', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848908, 'HP:0033533', 'Increased cardiac output', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848909, 'HP:0033533', 'Increased cardiac output', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848910, 'HP:0033533', 'Increased cardiac output', 'MP:0031302', 'syncope', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848911, 'HP:0033533', 'Increased cardiac output', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848912, 'HP:0033533', 'Increased cardiac output', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848913, 'HP:0033533', 'Increased cardiac output', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848914, 'HP:0033533', 'Increased cardiac output', 'MP:0005330', 'cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(848915, 'HP:0033533', 'Increased cardiac output', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848916, 'HP:0033533', 'Increased cardiac output', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(848917, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848918, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848919, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848920, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848921, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848922, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0013806', 'encephalopathy', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848923, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848924, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003463', 'abnormal single cell response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848925, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848926, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848927, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003470', 'abnormal summary potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848928, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848929, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848930, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848931, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848932, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848933, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0006080', 'brain ischemia', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848934, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848935, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848936, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848937, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848938, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848939, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848940, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848941, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848942, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848943, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848944, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0005402', 'abnormal action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848945, 'HP:0032854', 'Focal aware hemifacial clonic seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848946, 'HP:0100660', 'Dyskinesia', 'MP:0003633', 'abnormal nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(848947, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0003011', 'delayed dark adaptation', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(848948, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012035', 'abnormal b-wave shape', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848949, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012147', 'increased a-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848950, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(848951, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020974', 'abnormal FO-wave shape', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848952, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0006153', 'hypermetropia', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848953, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020960', 'increased c-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848954, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848955, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0010748', 'abnormal visual evoked potential', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848956, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020220', 'decreased tear production', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848957, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0006190', 'retina ischemia', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(848958, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012145', 'increased a-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848959, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0006150', 'double vision', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848960, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0006149', 'decreased visual acuity', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848961, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012040', 'abnormal c-wave shape', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848962, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0003100', 'myopia', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848963, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0014157', 'alacrima', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848964, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0013145', 'eye discharge', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(848965, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020978', 'abnormal FO-wave implicit time', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848966, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0004021', 'abnormal rod electrophysiology', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848967, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020219', 'increased tear production', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848968, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012144', 'decreased b-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848969, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0011832', 'abnormal visual acuity', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848970, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020959', 'decreased c-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848971, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020980', 'increased FO-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848972, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012037', 'abnormal b-wave latency', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848973, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848974, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0005258', 'ocular hypertension', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848975, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0003859', 'abnormal Harderian gland physiology', 0.4117647058823529, 9.175301480945878, 1.943724598723697, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(848976, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020958', 'abnormal c-wave implicit time', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848977, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0010749', 'absent visual evoked potential', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848978, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0003101', 'high myopia', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848979, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012153', 'increased b-wave latency', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848980, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020976', 'increased FO-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848981, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020962', 'increased c-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848982, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012038', 'abnormal a-wave implicit time', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848983, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020961', 'abnormal c-wave amplitude', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848984, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012030', 'abnormal a-wave amplitude', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848985, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0001999', 'photosensitivity', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848986, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012154', 'decreased b-wave latency', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848987, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020963', 'decreased c-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848988, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0008145', 'hemeralopia', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848989, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(848990, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0005253', 'abnormal eye physiology', 0.4642857142857143, 5.772412880326452, 1.6370854703693465, 'UPHENO:0075997', 'abnormal orbital region'),
(848991, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012152', 'decreased a-wave latency', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848992, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020977', 'decreased FO-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848993, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020979', 'decreased FO-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(848994, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012031', 'abnormal b-wave amplitude', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848995, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020860', 'abnormal cornea physiology', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848996, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0002090', 'abnormal vision', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(848997, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0005260', 'ocular hypotension', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(848998, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0005551', 'abnormal eye electrophysiology', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(848999, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0014132', 'abnormal tear film physiology', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(849000, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012036', 'abnormal a-wave latency', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(849001, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012039', 'abnormal b-wave implicit time', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(849002, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012146', 'increased b-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849003, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012148', 'decreased a-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849004, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0004022', 'abnormal cone electrophysiology', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849005, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012150', 'increased b-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849006, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0031497', 'increased visual acuity', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(849007, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0006251', 'eyelid apraxia', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849008, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0002001', 'blindness', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849009, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012151', 'increased a-wave latency', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849010, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012143', 'decreased a-wave amplitude', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849011, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0006152', 'tunnel vision', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849012, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012034', 'abnormal a-wave shape', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849013, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012149', 'decreased b-wave implicit time', 0.40625, 5.772412880326452, 1.5313532357469393, 'UPHENO:0075997', 'abnormal orbital region'),
(849014, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0005257', 'abnormal intraocular pressure', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849015, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012033', 'abnormal ERG implicit time', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849016, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0001337', 'dry eyes', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(849017, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020439', 'absent b-wave', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849018, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0012032', 'abnormal ERG latency', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849019, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0013468', 'chromodacryorrhea', 0.43333333333333335, 5.772412880326452, 1.5815748211223297, 'UPHENO:0075997', 'abnormal orbital region'),
(849020, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020975', 'abnormal FO-wave amplitude', 0.41935483870967744, 5.772412880326452, 1.5558564433761117, 'UPHENO:0075997', 'abnormal orbital region'),
(849021, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4666666666666667, 9.175301480945878, 2.0692528501308733, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(849022, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0003096', 'increased corneal light-scattering', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(849023, 'HP:0032039', 'Abnormality of the ocular adnexa', 'MP:0020218', 'abnormal tear production', 0.4482758620689655, 5.772412880326452, 1.608612246672995, 'UPHENO:0075997', 'abnormal orbital region'),
(849024, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0000851', 'cerebellum hypoplasia', 0.5769230769230769, 15.022184767190119, 2.9439166187231423, 'UPHENO:0081099', 'cerebellum hypoplasia'),
(849025, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0000912', 'small trigeminal motor nucleus', 0.40350877192982454, 9.35921975446769, 1.9433289143494499, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(849026, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0020533', 'decreased pons size', 0.40350877192982454, 9.35921975446769, 1.9433289143494499, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(849027, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0012263', 'decreased hindbrain size', 0.42592592592592593, 10.879226813348076, 2.152613470605775, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(849028, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0008914', 'enlarged cerebellum', 0.4074074074074074, 9.732678149995134, 1.9912722496485105, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(849029, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0000785', 'telencephalon hypoplasia', 0.4444444444444444, 8.202005804774931, 1.9092762799640346, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(849030, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0000910', 'small facial motor nucleus', 0.40350877192982454, 9.35921975446769, 1.9433289143494499, 'UPHENO:0081601', 'abnormal metencephalon morphology'),
(849031, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0000866', 'cerebellum vermis hypoplasia', 0.48214285714285715, 9.732678149995134, 2.1662274236308874, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(849032, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0020540', 'decreased cerebellum fastigial nucleus size', 0.41379310344827586, 9.732678149995134, 2.006817155734351, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(849033, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0000852', 'small cerebellum', 0.49019607843137253, 13.384754846574829, 2.561475031413792, 'UPHENO:0068984', 'decreased size of the cerebellum'),
(849034, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0012092', 'diencephalon hypoplasia', 0.4444444444444444, 8.202005804774931, 1.9092762799640346, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(849035, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0012264', 'hindbrain hypoplasia', 0.4642857142857143, 10.879226813348076, 2.2474584739014882, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(849036, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0012472', 'decreased cerebellum interpositus nucleus size', 0.42857142857142855, 9.732678149995134, 2.0423388011222188, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(849037, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0012488', 'decreased cerebellum dentate nucleus size', 0.42857142857142855, 9.732678149995134, 2.0423388011222188, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(849038, 'HP:0001321', 'Cerebellar hypoplasia', 'MP:0012262', 'abnormal hindbrain size', 0.40384615384615385, 10.879226813348076, 2.096075834837702, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(849039, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002923', 'increased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849040, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849041, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849042, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849043, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849044, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003889', 'enhanced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849045, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849046, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849047, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003467', 'abnormal single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849048, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849049, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849050, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849051, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009141', 'increased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849052, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849053, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849054, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849055, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003635', 'abnormal synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849056, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849057, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849058, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849059, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849060, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849061, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849062, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003477', 'abnormal nerve fiber response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849063, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849064, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849065, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013438', 'dysmyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849066, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849067, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849068, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849069, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849070, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003488', 'decreased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849071, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003469', 'decreased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849072, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849073, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012011', 'febrile seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849074, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849075, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849076, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849077, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849078, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849079, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002634', 'abnormal sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849080, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849081, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849082, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849083, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003471', 'abnormal summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849084, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849085, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001500', 'decreased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849086, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849087, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849088, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849089, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849090, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849091, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849092, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849093, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849094, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849095, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849096, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849097, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001473', 'reduced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849098, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849099, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849100, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849101, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003487', 'increased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849102, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849103, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849104, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849105, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003470', 'abnormal summary potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849106, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849107, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002635', 'reduced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849108, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849109, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003468', 'increased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849110, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849111, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849112, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011397', 'endoneurial edema', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849113, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849114, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849115, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849116, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001496', 'audiogenic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849117, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008921', 'increased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849118, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006060', 'increased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849119, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849120, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849121, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849122, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849123, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003489', 'increased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849124, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849125, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849126, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849127, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003216', 'absence seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849128, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009142', 'decreased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849129, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011994', 'increased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849130, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004859', 'abnormal synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849131, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003474', 'abnormal summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849132, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849133, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849134, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012006', 'abnormal hippocampus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849135, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003997', 'tonic-clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849136, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849137, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849138, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849139, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849140, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003475', 'increased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849141, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849142, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849143, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849144, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849145, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849146, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849147, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849148, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849149, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004811', 'abnormal neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849150, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002195', 'psychomotor seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849151, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849152, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849153, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849154, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849155, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849156, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003880', 'abnormal central pattern generator function', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849157, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009358', 'environmentally induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849158, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849159, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005402', 'abnormal action potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849160, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849161, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003464', 'abnormal single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849162, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849163, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006080', 'brain ischemia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849164, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849165, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849166, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849167, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849168, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849169, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849170, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849171, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849172, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849173, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849174, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014256', 'decreased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849175, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002207', 'abnormal long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849176, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849177, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849178, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849179, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849180, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849181, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849182, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849183, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001898', 'abnormal long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849184, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849185, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849186, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006058', 'decreased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849187, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849188, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849189, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849190, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003466', 'decreased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849191, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849192, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849193, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849194, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849195, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002917', 'decreased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849196, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849197, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849198, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849199, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849200, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849201, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849202, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849203, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849204, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849205, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003217', 'increased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849206, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849207, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849208, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849209, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849210, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849211, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849212, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849213, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849214, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004494', 'abnormal synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849215, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849216, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849217, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849218, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849219, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849220, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849221, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003486', 'abnormal channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849222, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849223, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849224, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849225, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849226, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849227, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003484', 'abnormal channel response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849228, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849229, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849230, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849231, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849232, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849233, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849234, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003008', 'enhanced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849235, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849236, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000920', 'abnormal myelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849237, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014255', 'increased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849238, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849239, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849240, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000921', 'demyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849241, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849242, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008814', 'decreased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849243, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004994', 'abnormal brain wave pattern', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849244, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849245, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849246, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849247, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849248, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849249, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849250, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003472', 'increased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849251, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849252, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010149', 'abnormal synaptic dopamine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849253, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003482', 'increased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849254, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849255, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849256, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003220', 'decreased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849257, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849258, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849259, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849260, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849261, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849262, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849263, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003480', 'increased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849264, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000951', 'sporadic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849265, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010050', 'hypermyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849266, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849267, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009967', 'abnormal neuron proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849268, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849269, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849270, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000947', 'convulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849271, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849272, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849273, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003088', 'abnormal prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849274, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849275, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849276, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003490', 'decreased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849277, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849278, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849279, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849280, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020424', 'increased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849281, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003485', 'abnormal channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849282, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849283, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849284, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849285, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021009', 'abnormal synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849286, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001900', 'impaired synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849287, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849288, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849289, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849290, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849291, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849292, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849293, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849294, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849295, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849296, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849297, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849298, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849299, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849300, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849301, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002915', 'abnormal synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849302, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849303, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849304, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849305, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849306, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003476', 'decreased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849307, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849308, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849309, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849310, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849311, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849312, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003219', 'increased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849313, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849314, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849315, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002193', 'minimal clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849316, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849317, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849318, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849319, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849320, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849321, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849322, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002920', 'decreased paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849323, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849324, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849325, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0014253', 'decreased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849326, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849327, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849328, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003218', 'decreased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849329, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849330, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003463', 'abnormal single cell response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849331, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849332, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849333, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849334, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0005403', 'abnormal nerve conduction', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849335, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849336, 'HP:0011212', 'EEG with photoparoxysmal response grade II', 'MP:0003633', 'abnormal nervous system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(849337, 'HP:0008273', 'Transient aminoaciduria', 'MP:0011517', 'hyperoxaluria', 0.43243243243243246, 10.47786425096631, 2.128607132549872, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(849338, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030620', 'valinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849339, 'HP:0008273', 'Transient aminoaciduria', 'MP:0011516', 'aspartylglucosaminuria', 0.5882352941176471, 11.226325483970346, 2.5697705876057757, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849340, 'HP:0008273', 'Transient aminoaciduria', 'MP:0011765', 'oroticaciduria', 0.5, 10.47786425096631, 2.2888713649926147, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(849341, 'HP:0008273', 'Transient aminoaciduria', 'MP:0011468', 'abnormal urine amino acid level', 0.40625, 11.094077685671904, 2.1229623312259243, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(849342, 'HP:0008273', 'Transient aminoaciduria', 'MP:0002931', 'glutaricadicuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(849343, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020406', 'hyperthreoninuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849344, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030632', 'increased urine creatine level', 0.4155844155844156, 11.094077685671904, 2.147213494612975, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(849345, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020404', 'prolinuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849346, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030617', 'hyperglutaminuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849347, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030614', 'methylmalonic aciduria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(849348, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030682', 'hydroxyprolinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849349, 'HP:0008273', 'Transient aminoaciduria', 'MP:0013730', 'glutathionuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849350, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020400', 'cystinuria', 0.547945205479452, 11.226325483970346, 2.4802038674458475, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849351, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020401', 'argininuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849352, 'HP:0008273', 'Transient aminoaciduria', 'MP:0011654', 'histidinuria', 0.547945205479452, 11.226325483970346, 2.4802038674458475, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849353, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020403', 'lysinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849354, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849355, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020402', 'ornithinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849356, 'HP:0008273', 'Transient aminoaciduria', 'MP:0020405', 'taurinuria', 0.5263157894736842, 11.226325483970346, 2.4307596261219233, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849357, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030689', 'cystathioninuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849358, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030615', 'ethylmalonic aciduria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(849359, 'HP:0008273', 'Transient aminoaciduria', 'MP:0003311', 'aminoaciduria', 0.5970149253731343, 11.226325483970346, 2.58887695169683, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849360, 'HP:0008273', 'Transient aminoaciduria', 'MP:0011470', 'increased urine creatinine level', 0.4507042253521127, 11.094077685671904, 2.2361010015911433, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(849361, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(849362, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030618', 'tryptophanuria', 0.547945205479452, 11.226325483970346, 2.4802038674458475, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849363, 'HP:0008273', 'Transient aminoaciduria', 'MP:0030616', 'hyperglycinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(849364, 'HP:0410338', 'Plant product allergy', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849365, 'HP:0410338', 'Plant product allergy', 'MP:0005001', 'abnormal clonal deletion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849366, 'HP:0410338', 'Plant product allergy', 'MP:0002419', 'abnormal innate immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849367, 'HP:0410338', 'Plant product allergy', 'MP:0020154', 'impaired humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849368, 'HP:0410338', 'Plant product allergy', 'MP:0005005', 'abnormal self tolerance', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849369, 'HP:0410338', 'Plant product allergy', 'MP:0001846', 'increased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849370, 'HP:0410338', 'Plant product allergy', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849371, 'HP:0410338', 'Plant product allergy', 'MP:0020155', 'enhanced humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849372, 'HP:0410338', 'Plant product allergy', 'MP:0001800', 'abnormal humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849373, 'HP:0410338', 'Plant product allergy', 'MP:0005671', 'abnormal response to transplant', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849374, 'HP:0410338', 'Plant product allergy', 'MP:0020002', 'increased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849375, 'HP:0410338', 'Plant product allergy', 'MP:0002420', 'abnormal adaptive immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849376, 'HP:0410338', 'Plant product allergy', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849377, 'HP:0410338', 'Plant product allergy', 'MP:0001876', 'decreased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849378, 'HP:0410338', 'Plant product allergy', 'MP:0003762', 'abnormal immune organ physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849379, 'HP:0410338', 'Plant product allergy', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849380, 'HP:0410338', 'Plant product allergy', 'MP:0002498', 'abnormal acute inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849381, 'HP:0410338', 'Plant product allergy', 'MP:0000392', 'accelerated hair follicle regression', 0.43243243243243246, 8.297292005324488, 1.8942064735568411, 'UPHENO:0054970', 'increased biological_process'),
(849382, 'HP:0410338', 'Plant product allergy', 'MP:0001845', 'abnormal inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849383, 'HP:0410338', 'Plant product allergy', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849384, 'HP:0410338', 'Plant product allergy', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849385, 'HP:0410338', 'Plant product allergy', 'MP:0004751', 'increased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849386, 'HP:0410338', 'Plant product allergy', 'MP:0003009', 'abnormal cytokine secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849387, 'HP:0410338', 'Plant product allergy', 'MP:0020001', 'decreased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849388, 'HP:0410338', 'Plant product allergy', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849389, 'HP:0410338', 'Plant product allergy', 'MP:0004752', 'decreased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849390, 'HP:0410338', 'Plant product allergy', 'MP:0005025', 'abnormal response to infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849391, 'HP:0410338', 'Plant product allergy', 'MP:0001790', 'abnormal immune system physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849392, 'HP:0410338', 'Plant product allergy', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849393, 'HP:0410338', 'Plant product allergy', 'MP:0002499', 'chronic inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849394, 'HP:0410338', 'Plant product allergy', 'MP:0020000', 'abnormal response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849395, 'HP:0410338', 'Plant product allergy', 'MP:0005000', 'abnormal immune tolerance', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849396, 'HP:0410338', 'Plant product allergy', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849397, 'HP:0410338', 'Plant product allergy', 'MP:0001835', 'abnormal antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849398, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0003009', 'abnormal cytokine secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849399, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0020000', 'abnormal response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849400, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001845', 'abnormal inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849401, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005025', 'abnormal response to infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849402, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0020154', 'impaired humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849403, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001835', 'abnormal antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849404, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0000392', 'accelerated hair follicle regression', 0.43243243243243246, 8.297292005324488, 1.8942064735568411, 'UPHENO:0054970', 'increased biological_process'),
(849405, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001876', 'decreased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849406, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849407, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849408, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849409, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0020002', 'increased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849410, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001800', 'abnormal humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849411, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005671', 'abnormal response to transplant', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849412, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005000', 'abnormal immune tolerance', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849413, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002498', 'abnormal acute inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849414, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0003762', 'abnormal immune organ physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849415, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001846', 'increased inflammatory response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849416, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0004751', 'increased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849417, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849418, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849419, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0020155', 'enhanced humoral immune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849420, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002419', 'abnormal innate immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849421, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005005', 'abnormal self tolerance', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849422, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002499', 'chronic inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849423, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849424, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849425, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849426, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005001', 'abnormal clonal deletion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849427, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0002420', 'abnormal adaptive immunity', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849428, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0004752', 'decreased length of allograft survival', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849429, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849430, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0020001', 'decreased response to antigen', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849431, 'HP:0500096', 'Venom-induced anaphylaxis', 'MP:0001790', 'abnormal immune system physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849432, 'HP:0009087', 'Posteriorly placed tongue', 'MP:0030606', 'abnormal gingival sulcus moprhology', 0.40816326530612246, 9.27922043240247, 1.9461338369147898, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(849433, 'HP:0009087', 'Posteriorly placed tongue', 'MP:0013818', 'abnormal oral cavity morphology', 0.425531914893617, 9.27922043240247, 1.987109569027385, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(849434, 'HP:0009087', 'Posteriorly placed tongue', 'MP:0021164', 'oral cleft', 0.40425531914893614, 7.503859459499253, 1.7416874290895694, 'UPHENO:0076800', 'abnormal mouth morphology'),
(849435, 'HP:0009087', 'Posteriorly placed tongue', 'MP:0000452', 'abnormal mouth morphology', 0.41304347826086957, 7.503859459499253, 1.760517029605877, 'UPHENO:0076800', 'abnormal mouth morphology'),
(849436, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000834', 'abnormal subthalamus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849437, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0004165', 'abnormal lateral geniculate nucleus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849438, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0030014', 'calcified brain', 0.4146341463414634, 6.213399309526074, 1.605081779406888, 'UPHENO:0076805', 'abnormal brain morphology'),
(849439, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000839', 'hypothalamus hyperplasia', 0.4117647058823529, 8.357638718648209, 1.8550958597482623, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849440, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0008927', 'abnormal parafascicular nucleus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849441, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020612', 'decreased thalamus cell density', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849442, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000830', 'abnormal diencephalon morphology', 0.425, 8.357638718648209, 1.884674097934571, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849443, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0012463', 'increased optic tract size', 0.4117647058823529, 8.357638718648209, 1.8550958597482623, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849444, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020527', 'small thalamus', 0.4583333333333333, 10.592196926445304, 2.2033512939657998, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849445, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020607', 'abnormal thalamus total cell area', 0.42857142857142855, 10.592196926445304, 2.1306132845912136, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849446, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020604', 'abnormal thalamus cell number', 0.42857142857142855, 10.592196926445304, 2.1306132845912136, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849447, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000840', 'abnormal epithalamus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849448, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0010369', 'abnormal thalamus neuron morphology', 0.4375, 10.592196926445304, 2.1526927684460273, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849449, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020553', 'abnormal stria medullaris size', 0.44, 10.592196926445304, 2.158834557726908, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849450, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020614', 'decreased thalamus average cell area', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849451, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020613', 'abnormal thalamus average cell area', 0.42857142857142855, 10.592196926445304, 2.1306132845912136, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849452, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020606', 'decreased thalamus cell number', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849453, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0012464', 'decreased optic tract size', 0.4117647058823529, 8.357638718648209, 1.8550958597482623, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849454, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0012481', 'increased habenula size', 0.44, 10.592196926445304, 2.158834557726908, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849455, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0012092', 'diencephalon hypoplasia', 0.4375, 8.357638718648209, 1.9121890438470228, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849456, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020608', 'decreased thalamus total cell area', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849457, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020555', 'increased stria medullaris size', 0.4074074074074074, 10.592196926445304, 2.077339521732495, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849458, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020605', 'increased thalamus cell number', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849459, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000831', 'diencephalon hyperplasia', 0.45652173913043476, 8.357638718648209, 1.9533160939441263, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849460, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020611', 'increased thalamus cell density', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849461, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020525', 'abnormal thalamus size', 0.5, 10.592196926445304, 2.301325371003121, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849462, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020530', 'disorganized thalamus', 0.5, 10.592196926445304, 2.301325371003121, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849463, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000771', 'abnormal brain size', 0.4146341463414634, 6.213399309526074, 1.605081779406888, 'UPHENO:0076805', 'abnormal brain morphology'),
(849464, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020557', 'abnormal ventromedial hypothalamic nucleus size', 0.4117647058823529, 8.357638718648209, 1.8550958597482623, 'UPHENO:0087516', 'abnormal diencephalon morphology'),
(849465, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000833', 'thalamus hyperplasia', 0.43137254901960786, 10.592196926445304, 2.137564733026433, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849466, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020528', 'thalamus hypoplasia', 0.41509433962264153, 10.592196926445304, 2.096845485088443, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849467, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0012482', 'decreased habenula size', 0.44, 10.592196926445304, 2.158834557726908, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849468, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020615', 'increased thalamus average cell area', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849469, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020554', 'decreased stria medullaris size', 0.4074074074074074, 10.592196926445304, 2.077339521732495, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849470, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0008930', 'abnormal medial geniculate nucleus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849471, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020526', 'enlarged thalamus', 0.4583333333333333, 10.592196926445304, 2.2033512939657998, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849472, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0000832', 'abnormal thalamus morphology', 0.43902439024390244, 10.592196926445304, 2.1564398431154967, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849473, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0008931', 'abnormal paraventricular thalamic nucleus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849474, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0008928', 'abnormal paracentral nucleus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849475, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020529', 'ectopic thalamus', 0.40425531914893614, 10.592196926445304, 2.069287787860482, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849476, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0008929', 'abnormal central medial nucleus morphology', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849477, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0012137', 'abnormal forebrain size', 0.45454545454545453, 9.371930806217245, 2.0639691248370373, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(849478, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020610', 'abnormal thalamus cell density', 0.42857142857142855, 10.592196926445304, 2.1306132845912136, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849479, 'HP:0031254', 'Thalamic arteriovenous malformation', 'MP:0020609', 'increased thalamus total cell area', 0.4186046511627907, 10.592196926445304, 2.105692973688762, 'UPHENO:0087517', 'abnormal dorsal plus ventral thalamus morphology'),
(849480, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849481, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849482, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849483, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849484, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849485, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849486, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849487, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849488, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849489, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849490, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849491, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849492, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849493, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849494, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849495, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849496, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849497, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849498, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849499, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849500, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849501, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849502, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849503, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849504, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849505, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849506, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849507, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849508, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849509, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849510, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849511, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849512, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849513, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849514, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849515, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849516, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849517, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849518, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849519, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849520, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849521, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849522, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849523, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849524, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849525, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849526, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849527, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849528, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849529, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849530, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849531, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849532, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849533, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849534, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849535, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849536, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849537, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849538, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849539, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849540, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849541, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849542, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849543, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849544, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849545, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849546, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849547, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849548, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849549, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849550, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849551, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849552, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849553, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849554, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849555, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849556, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849557, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849558, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849559, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849560, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849561, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849562, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849563, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849564, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849565, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849566, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849567, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849568, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849569, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849570, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849571, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849572, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849573, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849574, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849575, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849576, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849577, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849578, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849579, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849580, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849581, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849582, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849583, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849584, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849585, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849586, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849587, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849588, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849589, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849590, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849591, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849592, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849593, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849594, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849595, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849596, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849597, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849598, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849599, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849600, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849601, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849602, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849603, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849604, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849605, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849606, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849607, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849608, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849609, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849610, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849611, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849612, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849613, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849614, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849615, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849616, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849617, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849618, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849619, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849620, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849621, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849622, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849623, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849624, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849625, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849626, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849627, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849628, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849629, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849630, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849631, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849632, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849633, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849634, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849635, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849636, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849637, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849638, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849639, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849640, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849641, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849642, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849643, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849644, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849645, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849646, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849647, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849648, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849649, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849650, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849651, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849652, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849653, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849654, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849655, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849656, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849657, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849658, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849659, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849660, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849661, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849662, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849663, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849664, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849665, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849666, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849667, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849668, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849669, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849670, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849671, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849672, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849673, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849674, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849675, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849676, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849677, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849678, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849679, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849680, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849681, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849682, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849683, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849684, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849685, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849686, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849687, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849688, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849689, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849690, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849691, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849692, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849693, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849694, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849695, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849696, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849697, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849698, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849699, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849700, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849701, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849702, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849703, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849704, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849705, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849706, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849707, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849708, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849709, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849710, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849711, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849712, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849713, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849714, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849715, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849716, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849717, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849718, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849719, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849720, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849721, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849722, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849723, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849724, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849725, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849726, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849727, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849728, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849729, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849730, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849731, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849732, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849733, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849734, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849735, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849736, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849737, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849738, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849739, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849740, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849741, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849742, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849743, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849744, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849745, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849746, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849747, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849748, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849749, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849750, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849751, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849752, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849753, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849754, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849755, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849756, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849757, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849758, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849759, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849760, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849761, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849762, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849763, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849764, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849765, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849766, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849767, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849768, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849769, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849770, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849771, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849772, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849773, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849774, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849775, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849776, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849777, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849778, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849779, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849780, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849781, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849782, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849783, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849784, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849785, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849786, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849787, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849788, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849789, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849790, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849791, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849792, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849793, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849794, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849795, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849796, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849797, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849798, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849799, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849800, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849801, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849802, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849803, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849804, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849805, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849806, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849807, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849808, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849809, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849810, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849811, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849812, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849813, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849814, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849815, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849816, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849817, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849818, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849819, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849820, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849821, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849822, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849823, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849824, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849825, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849826, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849827, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849828, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849829, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849830, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849831, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849832, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849833, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849834, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849835, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849836, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849837, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849838, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849839, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849840, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849841, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849842, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849843, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849844, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849845, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849846, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849847, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849848, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849849, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849850, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849851, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849852, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849853, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849854, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849855, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849856, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849857, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849858, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849859, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849860, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849861, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849862, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849863, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849864, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849865, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849866, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849867, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849868, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849869, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849870, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849871, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849872, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849873, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849874, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849875, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849876, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849877, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849878, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849879, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849880, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849881, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849882, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849883, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849884, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849885, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849886, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849887, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849888, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849889, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849890, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849891, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849892, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849893, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849894, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849895, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849896, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849897, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849898, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849899, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849900, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849901, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849902, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849903, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849904, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849905, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849906, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849907, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849908, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849909, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849910, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849911, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849912, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849913, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849914, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849915, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849916, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849917, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849918, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849919, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849920, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849921, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849922, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849923, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849924, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849925, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849926, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849927, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849928, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849929, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849930, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849931, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849932, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849933, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849934, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849935, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849936, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849937, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849938, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849939, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849940, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849941, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849942, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849943, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849944, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849945, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849946, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849947, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849948, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849949, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849950, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849951, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849952, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849953, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849954, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849955, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849956, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849957, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849958, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849959, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849960, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849961, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849962, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849963, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849964, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849965, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849966, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849967, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849968, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849969, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849970, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849971, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849972, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849973, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849974, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849975, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849976, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849977, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849978, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849979, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849980, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849981, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849982, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849983, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849984, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849985, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849986, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849987, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849988, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849989, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849990, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849991, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849992, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849993, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849994, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849995, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849996, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849997, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(849998, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(849999, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850000, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850001, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850002, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850003, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850004, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850005, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850006, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850007, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850008, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850009, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850010, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850011, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850012, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850013, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850014, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850015, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850016, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850017, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850018, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850019, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850020, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850021, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850022, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850023, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850024, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850025, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850026, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850027, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850028, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850029, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850030, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850031, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850032, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850033, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850034, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850035, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850036, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850037, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850038, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850039, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850040, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850041, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850042, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850043, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850044, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850045, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850046, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850047, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850048, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850049, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850050, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850051, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850052, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850053, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850054, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850055, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850056, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850057, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850058, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850059, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850060, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850061, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850062, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850063, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850064, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850065, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850066, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850067, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850068, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850069, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850070, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850071, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850072, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850073, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850074, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850075, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850076, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850077, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850078, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850079, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850080, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850081, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850082, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850083, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850084, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850085, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850086, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850087, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850088, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850089, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850090, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850091, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850092, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850093, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850094, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850095, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850096, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850097, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850098, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850099, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850100, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850101, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850102, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850103, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850104, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850105, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850106, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850107, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850108, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850109, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850110, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850111, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850112, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850113, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850114, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850115, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850116, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850117, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850118, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850119, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850120, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850121, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850122, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850123, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850124, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850125, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850126, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850127, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850128, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850129, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850130, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850131, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850132, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850133, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850134, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850135, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850136, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850137, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850138, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850139, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850140, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850141, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850142, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850143, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850144, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850145, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850146, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850147, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850148, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850149, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850150, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850151, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850152, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850153, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850154, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850155, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850156, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850157, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850158, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850159, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850160, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850161, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850162, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850163, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850164, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850165, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850166, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850167, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850168, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850169, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850170, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850171, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850172, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850173, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850174, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850175, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850176, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850177, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850178, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850179, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850180, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850181, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850182, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850183, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850184, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850185, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850186, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850187, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850188, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850189, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850190, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850191, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850192, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850193, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850194, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850195, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850196, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850197, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850198, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850199, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850200, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850201, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850202, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850203, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850204, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850205, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850206, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850207, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850208, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850209, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850210, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850211, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850212, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850213, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850214, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850215, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850216, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850217, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850218, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850219, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850220, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850221, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850222, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850223, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850224, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850225, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850226, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850227, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850228, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850229, 'HP:0025629', 'Anti-myelin-associated glycoprotein antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850230, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850231, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850232, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850233, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850234, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850235, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850236, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850237, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850238, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850239, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850240, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850241, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850242, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850243, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850244, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850245, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850246, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850247, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850248, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850249, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850250, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850251, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850252, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850253, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850254, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850255, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850256, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850257, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850258, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850259, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850260, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850261, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850262, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850263, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850264, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850265, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850266, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850267, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850268, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850269, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850270, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850271, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850272, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850273, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850274, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850275, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850276, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850277, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850278, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850279, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850280, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850281, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850282, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850283, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850284, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850285, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850286, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850287, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850288, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850289, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850290, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850291, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850292, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850293, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850294, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850295, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850296, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850297, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850298, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850299, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850300, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850301, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850302, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850303, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850304, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850305, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850306, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850307, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850308, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850309, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850310, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850311, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850312, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850313, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850314, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850315, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850316, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850317, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850318, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850319, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850320, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850321, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850322, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850323, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850324, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850325, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850326, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850327, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850328, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850329, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850330, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850331, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850332, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850333, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850334, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850335, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850336, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850337, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850338, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850339, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850340, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850341, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850342, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850343, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850344, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850345, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850346, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850347, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850348, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850349, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850350, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850351, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850352, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850353, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850354, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850355, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850356, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850357, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850358, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850359, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850360, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850361, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850362, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850363, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850364, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850365, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850366, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850367, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850368, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850369, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850370, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850371, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850372, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850373, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850374, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850375, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850376, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850377, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850378, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850379, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850380, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850381, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850382, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850383, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850384, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850385, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850386, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850387, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850388, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850389, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850390, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850391, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850392, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850393, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850394, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850395, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850396, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850397, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850398, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850399, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850400, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850401, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850402, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850403, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850404, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850405, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850406, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850407, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850408, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850409, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850410, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850411, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850412, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850413, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(850414, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(850415, 'HP:0034061', 'Anti-steroid 17alpha-hydroxylase antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
